These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 31145302)
21. [The transfer of selective serotonin reuptake inhibitors to human milk]. Nordeng H; Bergsholm YK; Bøhler E; Spigset O Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200 [TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomised controlled trials. Jia Y; Zhu H; Leung SW BMJ Open; 2016 Jun; 6(6):e010142. PubMed ID: 27267106 [TBL] [Abstract][Full Text] [Related]
23. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study]. Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313 [TBL] [Abstract][Full Text] [Related]
24. A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indication. Rohde C; Hieronymus F; Østergaard SD Acta Psychiatr Scand; 2024 Oct; 150(4):198-208. PubMed ID: 38994727 [TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172 [TBL] [Abstract][Full Text] [Related]
26. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Edwards JG; Anderson I Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690 [TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of nine antidepressants in treating Chinese patients with post-stroke depression: A network meta-analysis. Li X; Zhang C J Affect Disord; 2020 Apr; 266():540-548. PubMed ID: 32056924 [TBL] [Abstract][Full Text] [Related]
28. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Mandrioli R; Mercolini L; Saracino MA; Raggi MA Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078 [TBL] [Abstract][Full Text] [Related]
29. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. Demyttenaere K; Corruble E; Hale A; Quera-Salva MA; Picarel-Blanchot F; Kasper S CNS Spectr; 2013 Jun; 18(3):163-70. PubMed ID: 23472671 [TBL] [Abstract][Full Text] [Related]
30. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Preskorn SH Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931 [TBL] [Abstract][Full Text] [Related]
32. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095 [TBL] [Abstract][Full Text] [Related]
33. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study. Lin YT; Lu TS; Hansen RA; Wang CC Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037 [TBL] [Abstract][Full Text] [Related]
34. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Kennedy SH; Andersen HF; Thase ME Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149 [TBL] [Abstract][Full Text] [Related]
35. Sertraline versus other antidepressive agents for depression. Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626 [TBL] [Abstract][Full Text] [Related]
36. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Amada N; Hirose T; Suzuki M; Kakumoto Y; Futamura T; Maeda K; Kikuchi T Neuropsychopharmacol Rep; 2023 Mar; 43(1):132-136. PubMed ID: 36649966 [TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis. Rao Y; Yang R; Zhao J; Cao Q Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):480-490. PubMed ID: 37202104 [TBL] [Abstract][Full Text] [Related]
39. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Orsolini L; Bellantuono C Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308 [TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis. Ma D; Zhang Z; Zhang X; Li L Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]